Tenofovir (TDF), a widely-prescribed antiretroviral therapy for patients infected with HIV, is associated with acute kidney injury (AKI), according to a new study that will be presented at ASN Kidney Week 2015, held Nov. 3-8, 2015 in San Diego. AKI is a costly, yet preventable, health burden linked to nephrotoxic medications, such as medical imaging dyes and anti-inflammatories, and a common postoperative complication.
The research team at Hospital das Clínicas de Pernambuco in Brazil.
Tenofovir (TDF), a widely-prescribed antiretroviral therapy for patients infected with HIV, is associated with acute kidney injury (AKI), according to a new study that will be presented at ASN Kidney Week 2015, held Nov. 3-8, 2015 in San Diego. AKI is a costly, yet preventable, health burden linked to nephrotoxic medications, such as medical imaging dyes and anti-inflammatories, and a common postoperative complication.
Researchers led by Teg Marcos Veiga, MD, of Hospital das Clínicas de Pernambuco in Brazil, retrospectively evaluated clinical characteristics and outcomes of AKI associated with the use of TDF in HIV inpatients between March 2011 and February 2015. Among 72 patients, nephrotoxic AKI occurred in 36 cases, 19 of which (26 percent) were associated with TDF. Of these 19, TDF nephrotoxicity was present in 7 patients without other associated factors.
Even though the drug was withdrawn in all cases, 37 percent of the patients needed hemodialysis and 58 percent did not completely recover their kidney function. Four of the patients died due to complications from sepsis, and 1 died from hemorrhagic shock. No patients became dialysis dependent.
“Since Tenofovir is a first-line therapy for HIV, infectious disease specialists and clinicians should be aware of the risk of nephrotoxicity related to its use, especially in the context of other drugs and factors that could increase AKI,” said Veiga.
Study: “Tenofovir Nephrotoxicity is an Important Cause of Acute Kidney Injury in HIV Infected Inpatients” (Abstract FR-PO481)
Source: American Society of Nephrology (ASN)
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.